Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 2,709 shares at $50.40 ($137K) on 2015-04-15, disclosed to the SEC on 2015-04-17.
Scheduled sale ($137k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.40 | 1,500 | $76K | 55.2% |
| 2 | $50.68 | 1,209 | $61K | 44.8% |
| Total | $50.52 avg | 2,709 | $137K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |